Tiny RNA molecules control labor, may be key to blocking premature birth

November 15, 2010

Nov. 15, 2010 – Tiny molecules called microRNAs act together with hormones to control the onset of labor, raising the prospect that RNA-based drugs might be able to prevent premature labor, researchers at UT Southwestern Medical Center have discovered in a preclinical study.

"With these findings, we understand better the system that controls labor, so with future research we might have the potential to manipulate it and prevent preterm birth," said Dr. Carole Mendelson, professor of biochemistry and obstetrics and gynecology at UT Southwestern and senior author of the study, which appears in an online issue of the .

Using pregnant mice as well as human uterine tissue, the researchers uncovered a feedback cycle involving microRNAs, proteins called ZEB1 and ZEB2, and the pregnancy-maintaining hormone , as well as genes and other factors that control contraction of the uterus.

"We've been struggling for a long time to understand how progesterone keeps the uterus from contracting during most of pregnancy," Dr. Mendelson said. "Our findings indicate that progesterone controls a family of microRNAs whose levels dramatically increase right before labor. At the same time, levels of the microRNAs' targets, the ZEB proteins, decrease. This enables uterine contractions."

MicroRNA is one form of , a chemical cousin of DNA. MicroRNAs interact with other protein-making molecules in cells, helping to fine-tune the expression of networks of genes and control cell function, Dr. Mendelson said.

In the new study, the researchers measured microRNA levels in the uteri of mice in mid-pregnancy and near labor. As labor approached, the level of a group of microRNAs called the miR-200 family greatly increased. When the researchers artificially stimulated premature labor, the miR-200 levels also increased.

The miR-200s block the production of two proteins called ZEB1 and ZEB2. In contrast, progesterone directly increases ZEB1 levels. The researchers uncovered a feedback cycle involving all these factors that prevents uterine contraction as long as progesterone is present.

"We found that during pregnancy, progesterone acts on the feedback loop to keep the microRNA levels down and the ZEBs up," said Nora Renthal, Medical Scientist Training Program student and lead author of the study. "The ZEBs, in turn, inhibit contraction-associate genes. But then, just prior to labor, there's a switch. Progesterone action decreases; the ZEBs are suppressed; the miR-200s increase; and the contraction-associated genes are turned on."

The researchers directly tested the contractility of cultured human uterine cells containing low or high levels of ZEB1 or ZEB2. In the presence of oxytocin, uterine cells with low levels of ZEBs contracted, while those with high levels did not, mirroring what happened in the pregnant mice.

While the study shows that the miR-200 family might be a likely therapeutic target to fight premature labor, the microRNAs and their interaction with the ZEB proteins also are known to play a role in cancer, so drug development would have to be approached very carefully, Dr. Mendelson said.

Related Stories

Recommended for you

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Age and gut bacteria contribute to multiple sclerosis disease progression

November 17, 2017
Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS) disease onset and progression.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

Prototype ear plug sensor could improve monitoring of vital signs

November 16, 2017
Scientists have developed a sensor that fits in the ear, with the aim of monitoring the heart, brain and lungs functions for health and fitness.

Ancient enzyme could boost power of liquid biopsies to detect and profile cancers

November 16, 2017
Scientists are developing a set of medical tests called liquid biopsies that can rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample. Researchers at The University ...

FDA to crack down on risky stem cell offerings

November 16, 2017
U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.